NCT03258645View on ClinicalTrials.gov

This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke

CompletedOBSERVATIONAL
Enrollment

1,489

Participants

Timeline

Start Date

November 15, 2018

Primary Completion Date

June 17, 2019

Study Completion Date

June 17, 2019

Conditions
Atrial Fibrillation
Interventions
DRUG

Dabigatran

Oral anticoagulant (NOAC) thrombin inhibitor

Trial Locations (1)

171 76

SITS International (c/o Karolinska University Hospital), Stockholm

Sponsors
All Listed Sponsors
collaborator

Karolinska University Hospital

OTHER

lead

Boehringer Ingelheim

INDUSTRY

NCT03258645 - This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke | Biotech Hunter | Biotech Hunter